RocketTickers

Akebia Therapeutics Announces Positive Top-Line Results from Glo

Long
NASDAQ:AKBA   Akebia Therapeutics, Inc
AKBA: Akebia Therapeutics
2020-05-05 06:59:00
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis